Home › Prostate Cancer
Prostate Cancer clinical trials recruiting in the U.S.
482 studies for Prostate Cancer are recruiting participants at sites across the United States.
Prostate cancer is one of the most common types of cancer among American men. The risk goes up as men age. Learn about symptoms, tests, and treatment.
Cities with the most studies
- New York City, NY101 studies
- Houston, TX73 studies
- Los Angeles, CA64 studies
- Boston, MA56 studies
- Seattle, WA45 studies
- St. Louis, MO45 studies
- Chicago, IL45 studies
- Baltimore, MD45 studies
- San Francisco, CA44 studies
- Philadelphia, PA41 studies
- Nashville, TN40 studies
- Washington, DC39 studies
- Dallas, TX39 studies
- Atlanta, GA36 studies
- Portland, OR33 studies
- San Diego, CA32 studies
- Durham, NC32 studies
- Baldwin Park, CA31 studies
- Cleveland, OH30 studies
- Miami, FL30 studies
- Madison, WI29 studies
- Edison, NJ29 studies
- Omaha, NE29 studies
- Queens, NY27 studies
- San Antonio, TX27 studies
- Ann Arbor, MI26 studies
- Columbus, OH25 studies
- Jacksonville, FL25 studies
- Myrtle Beach, SC23 studies
- Detroit, MI23 studies
- Pittsburgh, PA23 studies
- Minneapolis, MN22 studies
- Oklahoma City, OK22 studies
- New Haven, CT22 studies
- Grand Rapids, MI21 studies
- Rochester, MN20 studies
- Sacramento, CA20 studies
- Cincinnati, OH19 studies
- Denver, CO19 studies
- Milwaukee, WI19 studies
By state
- Alabama13 studies
- Alaska5 studies
- Arizona43 studies
- Arkansas13 studies
- California157 studies
- Colorado40 studies
- Connecticut29 studies
- Delaware10 studies
- District of Columbia17 studies
- Florida100 studies
- Georgia44 studies
- Hawaii6 studies
- Idaho13 studies
- Illinois65 studies
- Indiana22 studies
- Iowa17 studies
- Kansas21 studies
- Kentucky17 studies
- Louisiana23 studies
- Maine6 studies
- Maryland69 studies
- Massachusetts63 studies
- Michigan58 studies
- Minnesota47 studies
- Mississippi7 studies
- Missouri47 studies
- Montana17 studies
- Nebraska29 studies
- Nevada8 studies
- New Hampshire7 studies
- New Jersey43 studies
- New Mexico11 studies
- New York123 studies
- North Carolina47 studies
- North Dakota8 studies
- Ohio63 studies
- Oklahoma25 studies
- Oregon38 studies
- Pennsylvania62 studies
- Rhode Island8 studies
- South Carolina43 studies
- South Dakota8 studies
- Tennessee47 studies
- Texas113 studies
- Utah23 studies
- Vermont5 studies
- Virginia53 studies
- Washington55 studies
- West Virginia7 studies
- Wisconsin47 studies
- Wyoming6 studies
Recently updated studies
Hugo™ Robotic Assisted Surgery (RAS) System in Prostatectomy Patients Treated in an ASC Setting
RecruitingObservational study
Ages 18 and older · Men · Updated Nov 13, 2026 · NCT07875192Multitargeted Recombinant Ad5 PSA/MUC-1/Brachyury-Based Immunotherapy (TriAdeno) Vaccine With IL-15 Superagonist N-803 in Participants With Clinically Localized Prostate Cancer Undergoing Active Surveillance
RecruitingPhase 2
Ages 18 to 120 · Men · Updated Nov 13, 2026 · NCT07574541The Prostate Cancer, Genetic Risk, and Equitable Screening Study (ProGRESS)
RecruitingHealthy volunteers welcome
Ages 55 to 69 · Men · Updated Nov 13, 2026 · NCT05926102Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
RecruitingPhase 3
Ages 18 and older · Men · Updated Nov 13, 2026 · NCT04423211Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer
RecruitingPhase 1/2
Ages 18 to 120 · All sexes · Updated Nov 13, 2026 · NCT07667400Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells
RecruitingPhase 2
Ages 18 and older · Men · Updated Nov 12, 2026 · NCT05691465Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
RecruitingPhase 1
Ages 18 and older · Men · Updated Nov 12, 2026 · NCT04221542Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT03866382RYZ711 Diagnostic Platform Study
RecruitingPhase 1/2
Ages 18 and older · Men · Updated Nov 12, 2026 · NCT07862582Prospective Monitoring of Subjects With Biochemically Recurrent Prostate Cancer Using 18FDCFPyL
RecruitingObservational study
Ages 18 and older · Men · Updated Nov 12, 2026 · NCT05588128An Evidence-Based Focal Cryotherapy Protocol for Focal Ablation of Intermediate Risk Prostate Cancer
RecruitingPhase 2
Ages 18 and older · Men · Updated Nov 12, 2026 · NCT05454488Sacral Neuromodulation for Male Overactive Bladder (MOAB)
Recruiting
Ages 18 and older · Men · Updated Nov 12, 2026 · NCT06511141177Lu-PSMA-617 With Liver Directed Therapy in Metastatic Castration Resistant Prostate Cancer
RecruitingPhase 1
Ages 18 and older · Men · Updated Nov 12, 2026 · NCT07145177Imaging Studies to Check the Local Response of Prostate Cancer to Radiation Therapy
RecruitingObservational study
Ages 18 to 120 · Men · Updated Nov 12, 2026 · NCT01834001Collection of Blood From Patients With Prostate Cancer
RecruitingObservational study
Ages 18 and older · Men · Updated Nov 12, 2026 · NCT00923221A Comparison of Radical Prostatectomy and Precision Prostatectomy in Low- and Intermediate-risk Prostate Cancers.
Recruiting
All ages · Men · Updated Nov 12, 2026 · NCT07348367Care of the Prostate Cancer Patient and Prospective Procurement of Prostate Cancer Tissue
RecruitingObservational study
Ages 18 and older · Men · Updated Nov 12, 2026 · NCT02594202Surface Electrical Stimulation for Urinary Incontinence in Men Treated for Prostate Cancer
RecruitingPhase 2
Ages 18 to 120 · Men · Updated Nov 10, 2026 · NCT06161506Prostate Cancer Genetic Risk Evaluation and Screening Study
RecruitingObservational study
Ages 35 and older · Men · Updated Nov 10, 2026 · NCT05129605Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 10, 2026 · NCT04557449Collection of Blood From Patients With Cancer
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Nov 9, 2026 · NCT00034216Interstitial Assessment of Architectural Heterogeneity in Prostate Cancer Using a Fine Needle Photoacoustic Probe
RecruitingObservational study
Ages 40 to 80 · Men · Updated Nov 9, 2026 · NCT05965180Circulating Tumor DNA in High Risk Localized Prostate Cancer
RecruitingObservational study
Ages 18 and older · Men · Updated Nov 9, 2026 · NCT07222436PSCA-Targeting CAR-T Cells Plus or Minus Radiation for the Treatment of Patients With PSCA+ Metastatic Castration-Resistant Prostate Cancer
RecruitingPhase 1
Ages 18 and older · Men · Updated Nov 9, 2026 · NCT05805371First-Time-in-Human Study of GSK5471713 in Adults With mCRPC
RecruitingPhase 1/2
Ages 18 and older · Men · Updated Nov 9, 2026 · NCT07332455From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.